BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2349371)

  • 1. Naloxone induces miosis in normal subjects.
    Loimer N; Schmid R; Grünberger J; Linzmayer L
    Psychopharmacology (Berl); 1990; 101(2):282-3. PubMed ID: 2349371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mydriatic response to topical naloxone in opiate abusers.
    Ghodse AH; Bewley TH; Kearney MK; Smith SE
    Br J Psychiatry; 1986 Jan; 148():44-6. PubMed ID: 3955319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an endorphin dysfunction in methadone addicts: lack of ACTH response to naloxone.
    Gold MS; Pottash AL; Extein I; Martin DA; Finn LB; Sweeney DR; Kleber HD
    Drug Alcohol Depend; 1981 Nov; 8(3):257-62. PubMed ID: 6276118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone applied to conjunctiva as a test for physical opiate dependence.
    Creighton FJ; Ghodse AH
    Lancet; 1989 Apr; 1(8641):748-50. PubMed ID: 2564564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic naloxone administration, a potential treatment for migraine, enhances morphine-induced miosis.
    Nicolodi M; Sicuteri F
    Headache; 1992 Jul; 32(7):348-52. PubMed ID: 1526766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone eye drops reverse the miosis in runners--implications for an endogenous opiate test.
    Allen M; Thierman J; Hamilton D
    Can J Appl Sport Sci; 1983 Jun; 8(2):98-103. PubMed ID: 6883621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miosis and fluctuation in the rabbit pupil: effects of morphine and naloxone.
    Tallarida RJ; Kramer MS; Roy JW; Kester RA; Murray RB; Adler MW
    J Pharmacol Exp Ther; 1977 Jun; 201(3):587-92. PubMed ID: 864597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous buprenorphine reduces pupil size and the light reflex in humans.
    Pickworth WB; Bunker E; Welch P; Cone E
    Life Sci; 1991; 49(2):129-38. PubMed ID: 2062170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Feature extraction and pupil size detection of pupillary light reflex in opiate addicts].
    Zeng T; Shi YT; Peng QB; Chen NH; Ma YY
    Dongwuxue Yanjiu; 2010 Aug; 31(4):415-20. PubMed ID: 20740704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients.
    Grünberger J; Linzmayer L; Fodor G; Presslich O; Praitner M; Loimer N
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):109-12. PubMed ID: 2149649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pupillometry in healthy volunteers as a biomarker of tramadol efficacy.
    Matouskova O; Slanar O; Chytil L; Perlik F
    J Clin Pharm Ther; 2011 Aug; 36(4):513-7. PubMed ID: 21729116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers.
    Skulberg AK; Tylleskar I; Nilsen T; Skarra S; Salvesen Ø; Sand T; Loftsson T; Dale O
    Eur J Clin Pharmacol; 2018 Jul; 74(7):873-883. PubMed ID: 29568976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose naloxone on subjective alertness and pupil diameter in normal and narcoleptic subjects.
    Pressman MR; DiPhillipo MA; Forst-Paulus M; Fry JM
    Clin Neuropharmacol; 1986; 9(5):464-8. PubMed ID: 3768868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pupillometry in the detection of concomitant drug use in opioid-maintained patients.
    Murillo R; Crucilla C; Schmittner J; Hotchkiss E; Pickworth WB
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):271-5. PubMed ID: 15319805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular absorption of naloxone in narcotic addicts.
    Duncalf D; Jeyaram C; Tarter R; Foldes FF
    Int J Addict; 1975; 10(1):23-7. PubMed ID: 1126766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.
    Fanciullacci M; Sicuteri R; Alessandri M; Geppetti P
    Clin Pharmacol Ther; 1995 Mar; 57(3):349-55. PubMed ID: 7697953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.
    Rosow CE; Gomery P; Chen TY; Stefanovich P; Stambler N; Israel R
    Clin Pharmacol Ther; 2007 Jul; 82(1):48-53. PubMed ID: 17392726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptors in the rabbit iris.
    Drago F; Gorgone G; Spina F; Panissidi G; Dal Bello A; Moro F; Scapagnini U
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):1-4. PubMed ID: 6264328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.